EP1023076A4 - Utilisation du gene suppresseur de tumeur p-ten dans le diagnostic et le traitement de cancer - Google Patents
Utilisation du gene suppresseur de tumeur p-ten dans le diagnostic et le traitement de cancerInfo
- Publication number
- EP1023076A4 EP1023076A4 EP98908523A EP98908523A EP1023076A4 EP 1023076 A4 EP1023076 A4 EP 1023076A4 EP 98908523 A EP98908523 A EP 98908523A EP 98908523 A EP98908523 A EP 98908523A EP 1023076 A4 EP1023076 A4 EP 1023076A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- diagnosis
- cancer
- treatment
- tumor suppressor
- suppressor gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3694397P | 1997-02-07 | 1997-02-07 | |
| US36943P | 1997-02-07 | ||
| PCT/US1998/002615 WO1998034624A1 (fr) | 1997-02-07 | 1998-02-06 | Utilisation du gene suppresseur de tumeur p-ten dans le diagnostic et le traitement de cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP1023076A1 EP1023076A1 (fr) | 2000-08-02 |
| EP1023076A4 true EP1023076A4 (fr) | 2001-11-21 |
Family
ID=21891553
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP98908523A Withdrawn EP1023076A4 (fr) | 1997-02-07 | 1998-02-06 | Utilisation du gene suppresseur de tumeur p-ten dans le diagnostic et le traitement de cancer |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1023076A4 (fr) |
| AU (1) | AU6653698A (fr) |
| CA (1) | CA2280097A1 (fr) |
| WO (1) | WO1998034624A1 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6287854B1 (en) | 1996-10-22 | 2001-09-11 | Imperial Cancer Research Technology Limited | Diagnosis of susceptibility to cancer and treatment thereof |
| AU8479498A (en) * | 1997-07-08 | 1999-02-08 | Cold Spring Harbor Laboratory | Dual specificity phosphatase and methods of use |
| US6777439B2 (en) * | 2000-05-30 | 2004-08-17 | Advanced Research & Technology Institute, Inc. | Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways |
| WO2004074459A2 (fr) * | 2003-02-19 | 2004-09-02 | Georgetown University | Cellules deficientes en pten et utilisations de celles-ci |
| CN109022461B (zh) | 2017-06-08 | 2022-01-14 | 中山大学附属第一医院 | 一种PTEN基因的上游开放阅读框45aa-uORF核苷酸序列及其编码的多肽的应用 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998033907A1 (fr) * | 1997-01-30 | 1998-08-06 | Board Of Regents, The University Of Texas System | Suppresseur tumoral ts10q23.3 |
-
1998
- 1998-02-06 AU AU66536/98A patent/AU6653698A/en not_active Abandoned
- 1998-02-06 CA CA002280097A patent/CA2280097A1/fr not_active Abandoned
- 1998-02-06 WO PCT/US1998/002615 patent/WO1998034624A1/fr not_active Ceased
- 1998-02-06 EP EP98908523A patent/EP1023076A4/fr not_active Withdrawn
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998033907A1 (fr) * | 1997-01-30 | 1998-08-06 | Board Of Regents, The University Of Texas System | Suppresseur tumoral ts10q23.3 |
Non-Patent Citations (6)
| Title |
|---|
| LI D-M ET AL: "TEP1, ENCODED BY A CANDIDATE TUMOR SUPPRESSOR LOCUS, IS A NOVEL PROTEIN TYROSINE PHOSPHATASE REGULATED BY TRANSFORMING GROWTH FACTOR BETA1-", CANCER RESEARCH, vol. 57, 1 June 1997 (1997-06-01), pages 2124 - 2129, XP002066157, ISSN: 0008-5472 * |
| LIAW DANNY ET AL: "Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.", NATURE GENETICS, vol. 16, no. 1, 16 May 1997 (1997-05-16), pages 64 - 67, XP001024445, ISSN: 1061-4036 * |
| LO SU HAO ET AL: "Molecular cloning of chick cardiac muscle tensin: Full-length cDNA sequence, expression, and characterization.", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 269, no. 35, 1994, pages 22310 - 22319, XP002178161, ISSN: 0021-9258 * |
| MYERS ET AL: "P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatse", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 94, 1 August 1997 (1997-08-01), pages 9052 - 9057, XP002088258, ISSN: 0027-8424 * |
| NELEN M R ET AL: "Localization of the gene for Cowden disease to chromosome 10q22-23.", NATURE GENETICS, vol. 13, no. 1, 1996, pages 114 - 116, XP001024519, ISSN: 1061-4036 * |
| See also references of WO9834624A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2280097A1 (fr) | 1998-08-13 |
| EP1023076A1 (fr) | 2000-08-02 |
| WO1998034624A1 (fr) | 1998-08-13 |
| AU6653698A (en) | 1998-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0831904A4 (fr) | Traitement et diagnostic du cancer de la prostate | |
| DE69529307D1 (de) | Ultraschall-Diagnose- und Behandlungssystem | |
| EP0696919A4 (fr) | Diagnostic et traitement des dysfonctionnements erectiles | |
| BR9707125A (pt) | Composições e processos para o tratamento e diagnóstico de câncer de mama | |
| EP0926955A4 (fr) | Conjugues utiles dans le traitement du cancer de la prostate | |
| DE69535509D1 (de) | Medizinische diagnostische Bilddarstellungssystem und Verfahren | |
| FI965095A7 (fi) | Diatritsoksiesteri röntgenkontrastiaineina verenkiertojärjestelmän ja lymfaattisen järjestelmän kuvauksessa | |
| DK0806968T3 (da) | Diagnostiske billeddannelseskontrastmidler med foröget blodretention | |
| EP0696175A4 (fr) | Detection et diagnostic de traumas dans tissues corporelles | |
| FR2777466B1 (fr) | Appareil de traitement de tumeur | |
| IL110464A0 (en) | Novel proteins for the diagnosis, imaging, and therapy of human cancer | |
| ZA982968B (en) | Compositions and methods for the treatment and diagnosis of breast cancer | |
| EP0662001A4 (fr) | Ligands multifonctionnels potentiellement utiles pour realiser des agents therapeutiques ou de diagnostic par imagerie radiopharmaceutique. | |
| EP1567556A4 (fr) | Immunotoxine recombinante et son utilisation dans le traitement de tumeurs | |
| EP1100524A4 (fr) | Utilisation d'uteroglobine humaine de recombinaison dans le traitement d'etats inflammatoires et de type fibreux | |
| EP1214040A4 (fr) | Utilisation d'extraits de peau d'orange dans la prevention et le traitement du cancer | |
| EP1023076A4 (fr) | Utilisation du gene suppresseur de tumeur p-ten dans le diagnostic et le traitement de cancer | |
| AU1214995A (en) | Cdna probe for breast cancer diagnosis and treatment | |
| EP1546714A4 (fr) | Compositions et procedes d'utilisation de peptides de ciblage con us pour le diagnostic et le traitement du cancer humain | |
| EP0907720A4 (fr) | Radiotherapie et immunotherapie combinees pour le traitement du cancer | |
| EP1409734A4 (fr) | Diagnostic et traitement du cancer | |
| EP1322778A4 (fr) | Utilisation de cyr61 dans le traitement et le diagnostic des leiomyomes uterins chez la femme | |
| EP0871472A4 (fr) | Cytokines et leur utilisation dans le traitement et/ou la prophylaxie du cancer du sein | |
| GB9908059D0 (en) | Diagnosis and treatment of diseases | |
| EP1157694A4 (fr) | Agent therapeutique pour le traitement de la dyserection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19990831 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20011009 |
|
| AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| 17Q | First examination report despatched |
Effective date: 20030210 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20030821 |